Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Celiac disease and multiple sclerosis in the northwest of Iran.
Treatment selection and experience in multiple sclerosis: survey of neurologists.
Extracranial Venous abnormalities: A true pathological finding in patients with multiple sclerosis or an anatomical variant?
Progress in multiple sclerosis research in the last year.
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination.
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway.
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis.
The little compound that could: how phenytoin changed drug discovery and development.
Yield of emergent neuroimaging among children presenting with a first complex febrile seizure.
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial.
Treatment of walking impairment in multiple sclerosis with dalfampridine.
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.
Neuromyelitis optica.
CLARITY – Safety and Efficacy of Oral Cladribine in Subjects with Relapsing-remitting Multiple Sclerosis (MS)
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
Phase IV Study Reports Multiple Sclerosis Success with Teriflunomide
Amiloride Clinical Trial In Optic Neuritis (ACTION)
Sanofi sees US FDA ruling for MS drug Lemtrada in Q4
Reproductive issues in women with multiple sclerosis: ethical considerations.

Pages